Cited by 24Treatment of Major DepressionDementia and Cognitive Impairment ResearchNeurotransmitter Receptor Influence on Behavior

Longitudinal studies of cerebral glucose metabolism in late-life depression and normal aging

Open access
Marano, Christopher M., Workman, Clifford I., Kramer, Elisse, Hermann, Carol R., Ma, Yilong, Dhawan, Vijay, Chaly, Thomas, Eidelberg, David +1 more·2013·International Journal of Geriatric Psychiatry

Abstract

OBJECTIVE: Late-life depression (LLD) has a substantial public health impact and is both a risk factor for and a prodrome of dementia. Positron emission tomography (PET) studies of cerebral glucose metabolism have demonstrated sensitivity in evaluating neural circuitry involved in depression, aging, incipient cognitive decline, and dementia. The present study evaluated the long term effects of a course of antidepressant treatment on glucose metabolism in LLD patients. METHODS: Nine LLD patients and seven non-depressed control subjects underwent clinical and cognitive evaluations as well as brain magnetic resonance imaging and PET studies of cerebral glucose metabolism at baseline, after 8 weeks of treatment with citalopram for a major depressive episode (patients only), and at an approximately 2-year follow-up. RESULTS: The majority of LLD patients were remitted at follow-up (7/9). Neither patients nor controls showed significant cognitive decline. The patients showed greater increases in glucose metabolism than the controls in regions associated with mood symptoms (anterior cingulate and insula). Both groups showed decreases in metabolism in posterior association cortices implicated in dementia. CONCLUSIONS: Longitudinal changes in cerebral glucose metabolism are observed in controls and in LLD patients without significant cognitive decline that are more extensive than the decreases in brain volume. Longer duration follow-up studies and the integration of other molecular imaging methods will have implications for understanding the clinical and neurobiological significance of these metabolic changes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/gps.3840

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. First M Spitzer R Williams J Gibbon M 1995 Structured Clinical Interview for DSM-IV-Non-Patient Edition (SCID-NP, Version 1.0) American Psychiatric Press Washington, D.C

Cited by

Sorted by citations

Authors
Marano, C. M., Workman, C. I., Kramer, E., Hermann, C. R., Ma, Y., Dhawan, V., Chaly, T., Eidelberg, D., & Smith, G. S.
Affiliations
  • Johns Hopkins University (US)
  • Zucker Hillside Hospital (US)
  • Northwell Health (US)
Corresponding author
Smith, Gwenn S.
Venue
International Journal of Geriatric Psychiatry
Publisher
Wiley
Published
2012-06-27
Volume
28
Issue
4
Pages
417-423
ISSN
  • 0885-6230 (ISSN-L)
  • 1099-1166
OpenAlex
W1522731215
Cited by
24
References
31
Citations by year
2026: 1 · 2025: 1 · 2023: 1 · 2020: 1 · 2019: 3 · 2018: 3 · 2017: 2 · 2016: 2 · 2015: 2 · 2014: 2 · 2013: 6
FWCI
2.35
Type
journal article
Language
en
Open access
Locations
  • International Journal of Geriatric Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institute of Mental Health (R01 MH 86881, MH 01621, MH-49936, MH M01 RR 018535, R01MH064823, MH 57078, R01MH049936, MH 64823, R01MH057078, R01MH086881, K02MH001621)
  • National Center for Research Resources (M01RR018535)
Topics
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
geriatric depression, brain glucose metabolism, citalopram, antidepressant treatment, normal aging, cognitive decline, dementia risk, anterior cingulate cortex, insula, posterior association cortex, brain volume
MeSH terms
Aged, Aged, 80 and over, Aging, Cerebellum, Cognition Disorders, Major Depressive Disorder, Depressive Disorder, Major, Female, Glucose, Humans, Longitudinal Studies, Male, Citalopram, Age of Onset, Positron-Emission Tomography

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review